IL-17 and IFN-γ expression in lymphocytes from patients with active tuberculosis correlates with the severity of the disease

Journal of Leukocyte Biology

Volumn 91, Issue 6, 2012, Pages 991-1002

  Jurado, Javier O ^a   Pasquinelli, Virginia ^a   Alvarez, Ivana B ^a   Peña, Delfina ^a   Rovetta, Ana I ^a   Tateosian, Nancy L ^a   Romeo, Horacio E ^b   Musella, Rosa M ^c   Palmero, Domingo ^c   Eduardo Chuluyan H ^a   García, Verónica E ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b PONTIFICIA UNIVERSIDAD CATÓLICA ARGENTINA   (Argentina)

^c HOSPITAL F J MUÑIZ   (Argentina)

Author keywords

Costimulation; Cytokines; Th1 Th17 cells; Tuberculosis

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 17;

ADULT; ARTICLE; BCG VACCINATION; BLOOD; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; LUNG LESION; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OUTCOME ASSESSMENT; PLEURA FLUID; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; T LYMPHOCYTE; TH1 CELL; TH17 CELL; TUBERCULOSIS; UPREGULATION;

ADULT; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-17; MALE; MYCOBACTERIUM TUBERCULOSIS; SEVERITY OF ILLNESS INDEX; TH1 CELLS; TH17 CELLS; TUBERCULOSIS;

MYCOBACTERIUM TUBERCULOSIS;

EID: 84861926963     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1211619     Document Type: Article

References (35)

1. Cooper, A. M., Dalton, D. K., Stewart, T. A., Griffin, J. P., Russell, D. G., Orme, I. M. (1993) Disseminated tuberculosis in interferon γ gene-disrupted mice. J. Exp. Med. 178, 2243-2247.
2. Flynn, J. L., Chan, J., Triebold, K. J., Dalton, D. K., Stewart, T. A., Bloom, B. R. (1993) An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178, 2249-2254.
3. Newport, M. J., Huxley, C. M., Huston, S., Hawrylowicz, C. M., Oostra, B. A., Williamson, R., Levin, M. (1996) A mutation in the interferon-γ-receptor gene and susceptibility to mycobacterial infection. N. Engl. J. Med. 335, 1941-1949.
4. Holland, S. M. (2007) Interferon γ, IL-12, IL-12R and STAT-1 immunodeficiency diseases: disorders of the interface of innate and adaptive immunity. Immunol. Res. 38, 342-346.
5. Flynn, J. L. (2006) Lessons from experimental Mycobacterium tuberculosis infections. Microbes Infect. 8, 1179-1188.
6. Scriba, T. J., Kalsdorf, B., Abrahams, D. A., Isaacs, F., Hofmeister, J., Black, G., Hassan, H. Y., Wilkinson, R. J., Walzl, G., Gelderbloem, S. J., Mahomed, H., Hussey, G. D., Hanekom, W. A. (2008) Distinct, specific IL-17-and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response. J. Immunol. 180, 1962-1970.
7. Cooper, A. M. (2010) Editorial: be careful what you ask for: is the presence of IL-17 indicative of immunity? J. Leukoc. Biol. 88, 221-223.
8. Lazar-Molnar, E., Chen, B., Sweeney, K. A., Wang, E. J., Liu, W., Lin, J., Porcelli, S. A., Almo, S. C., Nathenson, S. G., Jacobs Jr., W. R. (2010) Programmed death-1 (PD-1)-deficient mice are extraordinarily sensitive to tuberculosis. Proc. Natl. Acad. Sci. USA 107, 13402-13407.
9. Torrado, E., Cooper, A. M. (2010) IL-17 and Th17 cells in tuberculosis. Cytokine Growth Factor Rev. 21, 455-462.
10. Khader, S. A., Cooper, A. M. (2008) IL-23 and IL-17 in tuberculosis. Cytokine 41, 79-83.
11. Mills, K. H. (2008) Induction, function and regulation of IL-17-producing T cells. Eur. J. Immunol. 38, 2636-2649.
12. Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., Kuchroo, V. K. (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441, 235-238.
13. Pasquinelli, V., Quiroga, M. F., Martinez, G. J., Zorrilla, L. C., Musella, R. M., Bracco, M. M., Belmonte, L., Malbran, A., Fainboim, L., Sieling, P. A., Garcia, V. E. (2004) Expression of signaling lymphocytic activation molecule-associated protein interrupts IFN-γ production in human tuberculosis. J. Immunol. 172, 1177-1185.
14. Mahuad, C., Bay, M. L., Farroni, M. A., Bozza, V., Del Rey, A., Besedovsky, H., Bottasso, O. A. (2004) Cortisol and dehydroepiandrosterone affect the response of peripheral blood mononuclear cells to mycobacterial antigens during tuberculosis. Scand. J. Immunol. 60, 639-646.
15. Sallusto, F., Geginat, J., Lanzavecchia, A. (2004) Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu. Rev. Immunol. 22, 745-763.
16. Boniface, K., Blumenschein, W. M., Brovont-Porth, K., McGeachy, M. J., Basham, B., Desai, B., Pierce, R., McClanahan, T. K., Sadekova, S., de Waal Malefyt, R. (2010) Human Th17 cells comprise heterogeneous subsets including IFN-γ-producing cells with distinct properties from the Th1 lineage. J. Immunol. 185, 679-687.
17. Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., Weaver, C. T. (2005) Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6, 1123-1132.
18. Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y. H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., Dong, C. (2005) A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 Nat. Immunol. 6, 1133-1141.
19. Pasquinelli, V., Townsend, J. C., Jurado, J. O., Alvarez, I. B., Quiroga, M. F., Barnes, P. F., Samten, B., Garcia, V. E. (2009) IFN-γ production during active tuberculosis is regulated by mechanisms that involve IL-17, SLAM, and CREB. J. Infect. Dis. 199, 661-665.
20. Thompson, C. B., Allison, J. P. (1997) The emerging role of CTLA-4 as an immune attenuator. Immunity 7, 445-450.
21. Oosterwegel, M. A., Greenwald, R. J., Mandelbrot, D. A., Lorsbach, R. B., Sharpe, A. H. (1999) CTLA-4 and T cell activation. Curr. Opin. Immunol. 11, 294-300.
22. Jurado, J. O., Alvarez, I. B., Pasquinelli, V., Martinez, G. J., Quiroga, M. F., Abbate, E., Musella, R. M., Chuluyan, H. E., Garcia, V. E. (2008) Programmed death (PD)-1: PD-ligand 1/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis. J. Immunol. 181, 116-125.
23. Veenstra, H., Baumann, R., Carroll, N. M., Lukey, P. T., Kidd, M., Beyers, N., Bolliger, C. T., van Helden, P. D., Walzl, G. (2006) Changes in leucocyte and lymphocyte subsets during tuberculosis treatment; prominence of CD3dimCD56+ natural killer T cells in fast treatment responders. Clin. Exp. Immunol. 145, 252-260.
24. Salgame, P. (2005) Host innate and Th1 responses and the bacterial factors that control Mycobacterium tuberculosis infection. Curr. Opin. Immunol. 17, 374-380.
25. Flesch, I., Kaufmann, S. H. (1987) Mycobacterial growth inhibition by interferon-γ-activated bone marrow macrophages and differential susceptibility among strains of Mycobacterium tuberculosis. J. Immunol. 138, 4408-4413.
26. Serbina, N. V., Lazarevic, V., Flynn, J. L. (2001) CD4(+) T cells are required for the development of cytotoxic CD8(+) T cells during Mycobacterium tuberculosis infection. J. Immunol. 167, 6991-7000.
27. Gong, J. H., Zhang, M., Modlin, R. L., Linsley, P. S., Iyer, D., Lin, Y., Barnes, P. F. (1996) Interleukin-10 downregulates Mycobacterium tuberculosis-induced Th1 responses and CTLA-4 expression. Infect. Immun. 64, 913-918.
28. Forbes, E. K., Sander, C., Ronan, E. O., McShane, H., Hill, A. V., Beverley, P. C., Tchilian, E. Z. (2008) Multifunctional, high-level cytokineproducing Th1 cells in the lung, but not spleen, correlate with protection against Mycobacterium tuberculosis aerosol challenge in mice. J. Immunol. 181, 4955-4964.
29. Flynn, J. L., Chan, J. (2001) Immunology of tuberculosis. Annu. Rev. Immunol. 19, 93-129.
30. Kebir, H., Ifergan, I., Alvarez, J. I., Bernard, M., Poirier, J., Arbour, N., Duquette, P., Prat, A. (2009) Preferential recruitment of interferon-γ-expressing TH17 cells in multiple sclerosis. Ann. Neurol. 66, 390-402.
31. Nistala, K., Adams, S., Cambrook, H., Ursu, S., Olivito, B., de Jager, W., Evans, J. G., Cimaz, R., Bajaj-Elliott, M., Wedderburn, L. R. (2010) Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment. Proc. Natl. Acad. Sci. USA 107, 14751-14756.
32. Annunziato, F., Cosmi, L., Santarlasci, V., Maggi, L., Liotta, F., Mazzinghi, B., Parente, E., Fili, L., Ferri, S., Frosali, F., Giudici, F., Romagnani, P., Parronchi, P., Tonelli, F., Maggi, E., Romagnani, S. (2007) Phenotypic and functional features of human Th17 cells. J. Exp. Med. 204, 1849-1861.
33. Lexberg, M. H., Taubner, A., Albrecht, I., Lepenies, I., Richter, A., Kamradt, T., Radbruch, A., Chang, H. D. (2010) IFN-γ and IL-12 synergize to convert in vivo generated Th17 into Th1/Th17 cells. Eur. J. Immunol. 40, 3017-3027.
34. Chen, X., Zhang, M., Liao, M., Graner, M. W., Wu, C., Yang, Q., Liu, H., Zhou, B. (2010) Reduced Th17 response in patients with tuberculosis correlates with IL-6R expression on CD4+ T Cells. Am. J. Respir. Crit. Care Med. 181, 734-742.
35. Alfaro, C., Murillo, O., Tirapu, I., Azpilicueta, A., Huarte, E., Arina, A., Arribillaga, L., Perez-Gracia, J. L., Bendandi, M., Prieto, J., Lasarte, J. J., Melero, I. (2006) [The immunotherapy potential of agonistic anti-CD137 (4-1BB) monoclonal antibodies for malignancies and chronic viral diseases]. An. Sist. Sanit. Navar. 29, 77-96.